Profile

Dr. Matt M. Roden is an Independent Director at iTeos Therapeutics, Inc., an Executive Partner at MPM Capital Inc, a President & Chief Executive Officer at Aktis Oncology, Inc., a President & Director at Celgene Corp. and a Chairman at Turmeric Acquisition Corp. He is on the Board of Directors at iTeos Therapeutics, Inc., Celgene Corp., BioNJ, Inc. and Nextpoint Therapeutics, Inc. Dr. Roden was previously employed as a Senior Vice President & Head-Enterprise Strategy by Bristol Myers Squibb Co., an Executive Director & Analyst by UBS Securities LLC, an Analyst by Merrill Lynch, Pierce, Fenner & Smith, Inc. (Old), a Head-Global Biotechnology Equity Research by UBS Investment Bank (New York), a Vice President by JPMorgan Securities, Inc., an Associate Analyst by Credit Suisse Securities (USA) LLC (Broker), and an Associate by Credit Suisse First Boston. He received his undergraduate degree from George Mason University, a graduate degree from Georgetown University and a doctorate degree from Albert Einstein College of Medicine, Inc..

Matt Roden active positions

CompaniesPositionStart
TURMERIC ACQUISITION CORP. Chairman -
CELGENE President 2019-11-19
Director/Board Member -
Chief Executive Officer 2020-08-31
Private Equity Investor 2020-07-31
Director/Board Member 2022-12-31
All active positions of Matt Roden

Former positions of Matt Roden

CompaniesPositionEnd
ITEOS THERAPEUTICS, INC. Director/Board Member 2023-02-02
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal 2019-12-31
Analyst-Equity 2016-04-30
░░░ ░░░░░░░░░░ ░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░░░ ░░░░░ ░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░░
See the detail of Matt Roden's experience

Training of Matt Roden

George Mason University Undergraduate Degree
Georgetown University Graduate Degree
Albert Einstein College of Medicine, Inc. Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Matt Roden's experience

Connections

99

1st degree connections

18

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
BRISTOL-MYERS SQUIBB COMPANY

Health Technology

ITEOS THERAPEUTICS, INC.

Health Technology

Private companies13

Health Technology

Finance

Finance

Finance

Finance

Finance

Finance

Commercial Services

UBS Investment Bank (New York)

Commercial Services

Finance

Health Services

Health Technology

See company connections
  1. Stock
  2. Insiders
  3. Matt Roden